BCR and B-cell chronic lymphocytic leukemia: Since CLL and other malignant B cells depend heavily on the BCR for survival signals and evasion of apoptosis, priming of malignant B cells to undergo apoptosis via BCR engagement following pre-treatment with a molecule to activate CD180 is an attractive treatment strategy.